Assembly Biosciences Inc (ASMB)
14.55
+0.65
(+4.68%)
USD |
NASDAQ |
May 15, 14:25
Assembly Biosciences Market Cap: 80.22M for May 15, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 14, 2024 | 76.63M |
| May 13, 2024 | 73.82M |
| May 10, 2024 | 73.88M |
| May 09, 2024 | 71.73M |
| May 08, 2024 | 70.85M |
| May 07, 2024 | 69.58M |
| May 06, 2024 | 70.85M |
| May 03, 2024 | 72.50M |
| May 02, 2024 | 70.23M |
| May 01, 2024 | 72.76M |
| April 30, 2024 | 68.37M |
| April 29, 2024 | 70.73M |
| April 26, 2024 | 69.36M |
| April 25, 2024 | 73.25M |
| April 24, 2024 | 73.91M |
| April 23, 2024 | 72.76M |
| April 22, 2024 | 72.48M |
| April 19, 2024 | 73.52M |
| April 18, 2024 | 73.09M |
| April 17, 2024 | 70.84M |
| April 16, 2024 | 79.61M |
| April 15, 2024 | 81.86M |
| April 12, 2024 | 80.32M |
| April 11, 2024 | 82.57M |
| April 10, 2024 | 80.49M |
| Date | Value |
|---|---|
| April 09, 2024 | 81.42M |
| April 08, 2024 | 78.95M |
| April 05, 2024 | 75.50M |
| April 04, 2024 | 74.79M |
| April 03, 2024 | 75.61M |
| April 02, 2024 | 74.02M |
| April 01, 2024 | 70.73M |
| March 28, 2024 | 72.92M |
| March 27, 2024 | 73.36M |
| March 26, 2024 | 71.61M |
| March 25, 2024 | 72.37M |
| March 22, 2024 | 71.17M |
| March 21, 2024 | 66.89M |
| March 20, 2024 | 67.93M |
| March 19, 2024 | 64.86M |
| March 18, 2024 | 64.70M |
| March 15, 2024 | 66.73M |
| March 14, 2024 | 66.07M |
| March 13, 2024 | 69.30M |
| March 12, 2024 | 70.07M |
| March 11, 2024 | 73.47M |
| March 08, 2024 | 74.46M |
| March 07, 2024 | 72.86M |
| March 06, 2024 | 72.43M |
| March 05, 2024 | 73.74M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
37.42M
Minimum
Oct 13 2023
887.13M
Maximum
Jul 20 2020
225.01M
Average
139.76M
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 3.498M |
| Palatin Technologies Inc | 33.16M |
| iBio Inc | 6.620M |
| Theriva Biologics Inc | 6.308M |
| Oragenics Inc | 7.214M |
Market Cap Related Metrics
| Price to Book Value | 2.461 |
| Price to Free Cash Flow | 2.581 |
| Price | 14.55 |
| Earnings Yield | -72.03% |